TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - PFIZER INC Stock

Certificat

DE000SQ7JRS1

Market Closed - Deutsche Boerse AG 04:45:00 2024-06-14 am EDT
2.28 EUR +0.44% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - PFIZER INC
Current month+3.64%
1 month+4.11%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 2.28 +0.44%
24-06-13 2.27 +1.79%
24-06-12 2.23 0.00%
24-06-11 2.23 +1.83%
24-06-10 2.19 +2.82%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 04:45 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ7JRS
ISINDE000SQ7JRS1
Date issued 2023-01-05
Strike 52.05 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.53
Lowest since issue 0.31

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.53 USD
Average target price
31.92 USD
Spread / Average Target
+15.93%
Consensus